CD44 in canine leukemia: Analysis of mRNA and protein expression in peripheral blood

被引:8
作者
Gelain, M. E. [1 ]
Martini, V. [2 ]
Giantin, M. [1 ]
Arico, A. [1 ]
Poggi, A. [3 ]
Aresu, L. [1 ]
Riondato, F. [3 ]
Dacasto, M. [1 ]
Comazzi, S. [2 ]
机构
[1] Univ Padua, Dipartimento Biomed Comparata & Alimentaz, I-35020 Agripolis Legnaro, PD, Italy
[2] Univ Milan, Dipartimento Sci Vet & Sanita Pubbl, I-20133 Milan, Italy
[3] Univ Turin, Dipartimento Sci Vet, I-10095 Grugliasco, TO, Italy
关键词
CD44; Dogs; Acute leukemia; Chronic lymphocytic leukemia; C-KIT MUTATIONS; SURVIVAL; LOCALIZATION; ACTIVATION; RECEPTOR;
D O I
10.1016/j.vetimm.2014.02.008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hyaluronan receptor CD44 mediates interaction between cells and extracellular matrix. The expression of standard form and its variants is dysregulated in human leukemias and is associated with metastasis and prognosis. The aim of this work is the evaluation of CD44 mRNA and protein expression in canine leukemia. Peripheral blood from 20 acute leukemias (AL) (10 acute lymphoblastic, 6 acute myeloid and 4 acute undifferentiated leukemias), 21 chronic lymphocytic leukemias (CLL) and thirteen healthy dogs were collected. The mRNA expression of all CD44 variants presenting exons 1-5 and/or 16-20 (CD44_ex1-5 and CD44_ex16-20) and CD44 protein were determined by real-time RT-PCR and flow cytometry, using the mean fluorescent index (MFI), respectively. CD44 MFI was significantly higher in leukemic samples compared to controls and a higher expression was found in AL in respect with CLL. No significant differences were found when considering different phenotypic subtypes of AL and CLL. CD44_ex1-5 mRNA expression was significantly higher in AL compared to controls, whereas there was no difference in CLL compared to controls and AL CD44_es16-20 showed the same trend, but without differences among groups. The high CD44 expression found in canine leukemias could be considered a step toward the definition of their molecular features. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:91 / 96
页数:6
相关论文
共 18 条
[1]   Increased c-kit intensity is a poor prognostic factor for progression-free and overall survival in patients with newly diagnosed AML [J].
Advani, Anjali S. ;
Rodriguez, Cristina ;
Jin, Tao ;
Abou Jawde, Rony ;
Saber, Wael ;
Baz, Rachid ;
Kalaycio, Matt ;
Sobecks, Ronald ;
Sekeres, Mikkael ;
Tripp, Barbara ;
Hsi, Eric .
LEUKEMIA RESEARCH, 2008, 32 (06) :913-918
[2]   Matrix metalloproteinases and vascular endothelial growth factor expression in canine leukaemias [J].
Arico, Arianna ;
Giantin, Mery ;
Gelain, Mariaelena ;
Riondato, Fulvio ;
Mortarino, Michele ;
Comazzi, Stefano ;
Dacasto, Mauro ;
Castagnaro, Massimo ;
Aresu, Luca .
VETERINARY JOURNAL, 2013, 196 (02) :260-262
[3]   Role of CD44 variant exon 6 in acute lymphoblastic leukaemia: association with altered bone marrow localisation and increased tumour burden [J].
Bendall, LJ ;
Nilsson, SK ;
Khan, NI ;
James, A ;
Bonnet, C ;
Lock, RB ;
Papa, R ;
Bradstock, KF ;
Gottlieb, DJ .
LEUKEMIA, 2004, 18 (07) :1308-1311
[4]   Evidence for a macromolecular complex in poor prognosis CLL that contains CD38, CD49d, CD44 and MMP-9 [J].
Buggins, Andrea G. S. ;
Levi, Ana ;
Gohil, Satyen ;
Fishlock, Keith ;
Patten, Piers E. M. ;
Calle, Yolanda ;
Yallop, Deborah ;
Devereux, Stephen .
BRITISH JOURNAL OF HAEMATOLOGY, 2011, 154 (02) :216-222
[5]   Immunophenotype Predicts Survival Time in Dogs with Chronic Lymphocytic Leukemia [J].
Comazzi, S. ;
Gelain, M. E. ;
Martini, V. ;
Riondato, F. ;
Miniscalco, B. ;
Marconato, L. ;
Stefanello, D. ;
Mortarino, M. .
JOURNAL OF VETERINARY INTERNAL MEDICINE, 2011, 25 (01) :100-106
[6]   CD44: target for antiangiogenesis therapy [J].
DeLisser, Horace M. .
BLOOD, 2009, 114 (25) :5114-5115
[7]   Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemia [J].
Eisterer, W ;
Bechter, O ;
Söderberg, O ;
Nilsson, K ;
Terol, M ;
Greil, R ;
Thaler, J ;
Herold, M ;
Finke, L ;
Günthert, U ;
Montserrat, E ;
Stauder, R .
LEUKEMIA RESEARCH, 2004, 28 (10) :1043-1051
[8]   CD44 regulates the apoptotic response and promotes disease development in chronic lymphocytic leukemia [J].
Fedorchenko, Oleg ;
Stiefelhagen, Marius ;
Peer-Zada, Abdul A. ;
Barthel, Romy ;
Mayer, Petra ;
Eckei, Laura ;
Breuer, Alexandra ;
Crispatzu, Giuliano ;
Rosen, Natascha ;
Landwehr, Thomas ;
Lilienthal, Nils ;
Moellmann, Michael ;
Montesinos-Rongen, Manuel ;
Heukamp, Lukas ;
Duerig, Jan ;
Hallek, Michael ;
Fingerle-Rowson, Guenter ;
Herling, Marco .
BLOOD, 2013, 121 (20) :4126-4136
[9]   Evaluation of tyrosine-kinase receptor c-KIT (c-KIT) mutations, mRNA and protein expression in canine leukemia: Might c-KIT represent a therapeutic target? [J].
Giantin, M. ;
Aresu, L. ;
Arico, A. ;
Gelain, M. E. ;
Riondato, F. ;
Martini, V. ;
Comazzi, S. ;
Dacasto, M. .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2013, 152 (3-4) :325-332
[10]   Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1 [J].
Herishanu, Yair ;
Gibellini, Federica ;
Njuguna, Ndegwa ;
Hazan-Halevy, Inbal ;
Farooqui, Mohammed ;
Bern, Sarah ;
Keyvanfar, Keyvan ;
Lee, Elinor ;
Wilson, Wyndham ;
Wiestner, Adrian .
LEUKEMIA & LYMPHOMA, 2011, 52 (09) :1758-1769